PotlatchDeltic Board Declares Distribution on Common Stock

Deadline
Anouk Aimée Dies: Iconic Star Of Cinema Classics ‘La Dolce Vita’ & ‘8½’ Was 92
Anouk Aimée, the French star of classic titles like Federico Fellini’s La Dolce Vita and Jacques Demy’s Lola has died. She was 92. Aimée’s daughter, Manuela Papatakis, shared the news with a post on social media Tuesday morning. “With my daughter, Galaad, and my granddaughter, Mila, we have great sadness to announce the departure of …
Yahoo Finance
Stock market today: S&P 500, Nasdaq hover near record highs ahead of retail sales data
Techs are continuing to lead an AI-driven rally that investors simply can't afford to miss out on.
Business Wire
Net Asset Value(s)
LONDON, June 18, 2024-- FundsDate
Yahoo Finance Video
Shrinkflation, shoplifting, and self-checkout
Target (TGT), Macy's (M), Best Buy (BBY), were hit hard by 'rampant shoplifting' and shrinkflation, according to investor and market commentator, Jeff Macke. He joined Yahoo Finance Executive Editor Brian Sozzi on Opening Bid to discuss the difficulties and errors retailer made over recent years; specifically, self-checkout. 'Self-check was just one of the great debacle in retail history. The idea that, that people can just be trusted to check themselves out of stores. Geez,' he added. For full episodes of Opening Bid, watch on our website or listen on your favorite podcast platform.
Yahoo Finance Video
Citi raises its S&P 500 target, Boeing CEO testifies: Yahoo Finance
The S&P 500 (^GSPC) continues to get bullish calls, with Citi joining Goldman Sachs and Evercore ISI as the latest bank to raise its year-end target for the index. Citi and Goldman Sachs have raised their targets to 5,600 while Evercore ISI has raised it to 6,000. As the tech sector continues to push the market to new heights, the Technology Select Sector SPDR Fund (XLK) is set to give Nvidia (NVDA) a 20% weighting while cutting back on Apple (AAPL). Meanwhile, Boeing (BA) CEO David Calhoun heads to Capitol Hill to testify on the company’s various safety concerns. Wall Street is also digesting May’s retail sales report. Yahoo Finance trending tickers include Mustang Bio (MBIO), Qualcomm (QCOM), and Palantir (PLTR). Key guests include:9:00 a.m. ET - Scott Chronert, Citi Head of U.S. Equity Strategy9:30 a.m. ET - Matthew Luzzetti, Deutsche Bank Chief U.S. Economist10:00 a.m. ET - Wei Li, BlackRock Global Chief Investment Strategist10:45 a.m. ET - Amy Wu Silverman, RBC Capital Markets Equity Derivatives Strategist11:15 a.m. ET - Paul Knopp, KPMG U.S. CEO
GlobeNewswire
Altimmune Announces Oral Presentations of Pemvidutide Clinical Data at Upcoming American Diabetes Association’s Scientific Sessions
GAITHERSBURG, Md., June 18, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced oral presentations on pemvidutide, an investigational GLP-1/glucagon dual receptor agonist in development for the treatment of obesity and MASH, at the American Diabetes Association’s (ADA) 84th Scientific Sessions, to be held in Orlando, FL from June 21-24, 2024. Details for the oral presentations are as follows: Session Title:Leveling Up Incretin-Based
GlobeNewswire
HPQ Silicon Welcomes Canada's Recognition of Silicon Metal as a Critical Mineral
The addition will enhance the value of HPQ’s innovative and sustainable silicon production technologies while supporting Canada’s efforts to reshore industrial supply chainsMONTREAL, June 18, 2024 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ) (OTCQB: HPQFF) (FRA: O08), a technology company specializing in green engineering processes for silica and silicon material production, is pleased to announce its support for the Government of Canada's latest expansion of the Cr
GlobeNewswire
Super Hi Reports Unaudited Financial Results for the First Quarter of 2024
SINGAPORE, June 18, 2024 (GLOBE NEWSWIRE) -- Super Hi International Holding Ltd. (NASDAQ: HDL and HKEX: 9658) (“Super Hi” or the “Company”), a leading Chinese cuisine restaurant brand operating Haidilao hot pot restaurants in the international market, today announced its unaudited financial results for the first quarter of FY2024 ended March 31, 2024. First Quarter 2024 Highlights Revenue was US$187.6 million, representing an increase of 16.6% from US$160.9 million in the same period of 2023.Ope
GlobeNewswire
Aduro Clean Technologies Announces Closing of Non-Brokered Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES LONDON, Ontario, June 18, 2024 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQX: ACTHF) (FSE: 9D50), a Canadian technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewal oils, into resources for the 21st century, is pleased to announce that, further to its news release dated May 2
GlobeNewswire
Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome
Durable improvements across consistent clinical domains in both adult and pediatric patients, including motor skills, communication/socialization, autonomic function, seizures, and an encouraging safety profile seen across adult (up to 52 weeks) and pediatric (up to 22 weeks) patients with different genetic mutation severity Longer-term data from both adult patients showed sustained and new improvements across multiple efficacy measures and clinical domains following the completion of steroid ta
GlobeNewswire
Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
In Study 502, lumateperone 42 mg achieved statistically significant and clinically meaningful results in both the primary and the key secondary endpoints Lumateperone 42 mg met the primary endpoint of change from baseline at Week 6 on the Montgomery-Åsberg Depression Rating Scale (MADRS) total score versus placebo (4.5 point reduction v. placebo; p<0.0001; Cohen’s d effect size (ES)=0.56) Lumateperone 42 mg also met the key secondary endpoint of change from baseline at Week 6 on the Clinical Glo
GlobeNewswire
Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group
With today’s announcement of the transaction completion, Grifols and Haier Group will work together through Shanghai RAAS (SRAAS) to drive synergies that enhance China’s healthcare systemThrough a share purchase agreement Grifols has sold a 20% equity stake in SRAAS to Haier Group for RMB 12.5 billion (approximately EUR 1.6 billion)Grifols and SRAAS extend their exclusive albumin distribution agreement over the next 10 years, and SRAAS has the option to prolong it through 2044Grifols will use al
GlobeNewswire
DeFi Technologies Subsidiary Valour Inc. Introduces World’s First and Only Yield Bearing Bitcoin (BTC) ETP in Collaboration with Core Foundation, to German Investors on Börse Frankfurt Offering Exposure to Bitcoin with a 5.65% Yield
Launch of Yield-Bearing Bitcoin (BTC) ETP on Börse Frankfurt: Valour Inc. and Core Foundation collaborate to introduce the world's first yield-bearing Bitcoin (“BTC”) ETP on the Börse Frankfurt Exchange, previously launched on the Nordic Growth Market (“NGM”) with a 1.9% management fee, offering German investors exposure to Bitcoin with a 5.65% yield.Powering Valour Bitcoin Staking (BTC) EUR ETP with Core Blockchain: The Core blockchain network, powered by Bitcoin, forms the foundation for Valou
Business Wire
KUBRA Launches Advanced Analytics Solution to Transform Data Insights for Utilities
TEMPE, Ariz., June 18, 2024--KUBRA is excited to announce the launch of its innovative business intelligence tool, KUBRA BizInsights™.
GlobeNewswire
Houston Firm Strengthens Tax & Risk Expertise with New Hires
HOUSTON, June 18, 2024 (GLOBE NEWSWIRE) -- Calvetti Ferguson announces the appointments of two new Houston directors to its growing team: Andrea Ontiveros as Tax Incentives Director and Chris Komarek as Risk Advisory Director. Andrea Ontiveros brings a wealth of leadership experience and a proven success record to her new tax incentives director role. With over eight years of experience in R&D tax credits and other incentives, Andrea deeply understands optimizing these valuable tax benefits for
Business Wire
Armis Named to Inc.’s 2024 Best Workplaces List
SAN FRANCISCO, June 18, 2024--Armis, the asset intelligence cybersecurity company, today announced that it has been named to Inc.’s annual Best Workplaces list, which honors employers of choice.
GlobeNewswire
The Habit Burger Grill Opens 11th Restaurant in New Jersey With Hamilton Drive-Thru Location
The Habit Burger Grill to Open Its Doors to the Public on June 18IRVINE, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- The Habit Burger Grill, the California-based restaurant company renowned for its award-winning Charburgers grilled over an open flame, signature sandwiches, fresh salads, and more, announces today the launch of their 11th restaurant in New Jersey with their Hamilton drive-thru opening. The restaurant and drive-thru are located at 1227 State Hwy 33, Hamilton, NJ 08690, and their famo
GlobeNewswire
Zevra Therapeutics Transitions to Orsini as the Specialty Pharmacy Provider for OLPRUVA® (sodium phenylbutyrate), a Treatment for Certain Urea Cycle Disorders
CELEBRATION, Fla. and ELK GROVE VILLAGE, Ill., June 18, 2024 (GLOBE NEWSWIRE) -- Orsini Specialty Pharmacy (Orsini), and Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra) today announced that Orsini is now the pharmacy partner for OLPRUVA® (sodium phenylbutyrate) for oral suspension. OLPRUVA® is a prescription medicine used along with certain therapies, including changes in diet, for long-term management of certain adult and pediatric patients with urea cycle disorders (UCDs) involving deficienc
GlobeNewswire
America’s Car-Mart Reports Fourth Quarter and Fiscal Year 2024 Results
ROGERS, Ark., June 18, 2024 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ: CRMT) (“we,” “Car-Mart” or the “Company”), today reported financial results for the fourth quarter and full year ended April 30, 2024. Fourth Quarter Key Highlights (FY’24 Q4 vs. FY’23 Q4, unless otherwise noted) Revenue was $364.7 million, down 5.8%Gross Margin improved to 35.5%, up 200 bpsTotal collections increased 5.0% to $187.2 millionFavorable adjustment to allowance for credit loss to 25.32%, down from 25.74
GlobeNewswire
Vyluma Meets with FDA on Atropine Sulfate Ophthalmic Solution 0.01% Under Development to Treat Pediatric Myopia
Vyluma Discusses Response to FDA’s Questions and Clarifies Regulatory Pathway for its 505(b)(2) NDABRIDGEWATER, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- Vyluma, Inc. (“Vyluma”), a clinical stage pharmaceutical company is focused on the development of ophthalmic treatments for disease states with limited treatment options. On June 4, 2024, the Company had a Type A meeting with representatives of the U.S. Food and Drug Administration’s (FDA’s) Division of Ophthalmology to discuss the response to FD

NZX 50

NZD/USD

ALL ORDS

OIL

GOLD

PotlatchDeltic Board Declares Distribution on Common Stock

Latest stories

Anouk Aimée Dies: Iconic Star Of Cinema Classics ‘La Dolce Vita’ & ‘8½’ Was 92

Stock market today: S&P 500, Nasdaq hover near record highs ahead of retail sales data

Net Asset Value(s)

Shrinkflation, shoplifting, and self-checkout

Citi raises its S&P 500 target, Boeing CEO testifies: Yahoo Finance

Altimmune Announces Oral Presentations of Pemvidutide Clinical Data at Upcoming American Diabetes Association’s Scientific Sessions

HPQ Silicon Welcomes Canada's Recognition of Silicon Metal as a Critical Mineral

Super Hi Reports Unaudited Financial Results for the First Quarter of 2024

Aduro Clean Technologies Announces Closing of Non-Brokered Private Placement

Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome

Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group

DeFi Technologies Subsidiary Valour Inc. Introduces World’s First and Only Yield Bearing Bitcoin (BTC) ETP in Collaboration with Core Foundation, to German Investors on Börse Frankfurt Offering Exposure to Bitcoin with a 5.65% Yield

KUBRA Launches Advanced Analytics Solution to Transform Data Insights for Utilities

Houston Firm Strengthens Tax & Risk Expertise with New Hires

Armis Named to Inc.’s 2024 Best Workplaces List

The Habit Burger Grill Opens 11th Restaurant in New Jersey With Hamilton Drive-Thru Location

Zevra Therapeutics Transitions to Orsini as the Specialty Pharmacy Provider for OLPRUVA® (sodium phenylbutyrate), a Treatment for Certain Urea Cycle Disorders

America’s Car-Mart Reports Fourth Quarter and Fiscal Year 2024 Results

Vyluma Meets with FDA on Atropine Sulfate Ophthalmic Solution 0.01% Under Development to Treat Pediatric Myopia